The Solution is Cathaid™

Cathaid™ seamlessly replaces the flawed standard of care with one simple to use device. Cathaid™ gives clinicians the ability to detect positional shifts, secure the catheter, and provides a full medical seal around the entry site. These all act to safeguard the patient while adding fidelity to high risk medical catheters. The patented ability to detect positional shifts is a market first capability. Cathaid™ is poised to replace a clumsy standard of care that simply does not provide adequate protections for medical catheters. 

Cathaid™ can also be manufactured to accommodate the differing types of catheters available on the market. This allows for flexibility in how Cathaid™ can be applied in differing medical fields while maintaining its designed functionality. 

cathaid v2 details.PNG


Positional Alert

Cathaid's Positional Verification System allows clinicians the ability to detect dangerous positional shifts without using radio-graphic methods. Health care providers of all levels can easily detect changes through the easy to use positional indicator.



Cathaid's antimicrobial adhesive film technology can be tailored to the clinicians' specification. Antimicrobial protection can range from basic Chlorhexidine impregnation for low risk usage to multi-substance, multi-organism protection for high risk medical catheters.  



By applying Cathaid to a medical catheter, a clinician can be assured that optimal positioning will be held during the lifetime of catheter usage.  Cathaid's securement mechanism locks the catheter securely between the foundation cover and base with a strong layer of medical grade adhesive.  The strength of adhesive can be varied according to clinical usage (high vs low tension situation).

Easy to Installation and Removal


Medical catheters are invaluable tools in modern medicine and their usage extends into almost every aspect of modern medicine. Each year, over 300 million medical catheters are used around the world. While they are a invaluable tool for doctors, their use is not without risks. Catheter associated infections and inadvertent positional shifts are a major source of morbidity and mortality for patients.


Even with the standard of care using up to four products to protect the catheter, 25% of catheters will experience a failure due to infection and other complications. Additionally, health care providers are unable to assess positional changes without utilizing radio-graphic imaging. This exposes the patient to unnecessary radiation and is financially costly for the healthcare system. 


John W. Richards, Jr., MD, MMM, CPE
  • Serial entrepreneur with over 30 companies

  • Pioneered concepts & products in pharma, HC delivery, HC technology, health promotion, disease prevention & mgmt, cost containment, managed care & disaster mgmt.

  • Built one of the first mail order pharmacies, PBMs, specialty injectable, in-home infusion, physician in-office dispensing, health data AI predictive modeling, nurse coaching, wellness, tele-medicine, physician negotiation, and physician-led precertification programs.

George Hsu, MD
  • Assistant Professor Pediatric Emergency Medicine

  • Experienced Medical Device and Healthcare IT Innovator

  • Executive Director Center Medical Innovation 

  • Experienced Educator and Clinician 

  • Board Certified: General Pediatrics and Pediatric Emergency Medicine

  • Undergraduate/Graduate: Georgia Institute of Technology, Georgia State University,

  • Medical School: Mercer University School of Medicine 

  • Residency/Fellowship: Augusta University Children's Hospital of Georgia

Xiaoyu Alan Zheng, MS
  • Mechanical Engineer at the National Institute of Standards and Technology (NIST)

  • Over 15 years experience in mechanical engineering with extensive experience in CAD design, 3D printing, and prototyping

  • University of Maryland (BC): Bachelors, Mechanical Engineering. Johns Hopkins: Masters, Mechanical Engineering with a focus on manufacturing and rapid prototyping

  • Published over 25 articles in scientific research journals

Lou Malice
  • Former CEO of NFANT Labs, a medical device company that transforms a baby bottle into a smart device which measures infant tongue movement

  • Medical Device Executive with 30+ years of experience in commercialization, R&D, manufacturing, supply chain, and regulatory

  • Veteran of start-up & growth stage medical device companies

  • Acquisition and rollup expert

Matthew Tyrmand
  • Corporate Finance & Healthcare Sector Industry Analyst

  • Long time buy side portfolio manager of healthcare equities across biotechnology, medical technology, consumables, dental, ortho, cardio/vascular tech, drug development, specialty services, managed care, drug distribution/PBMs, healthcare IT, and other sub-sector industry verticals

  • Early stage private company corporate finance advisory and capital raising specialist affiliated with boutique investment bank- focus on healthcare and TMT (Tech/Media/Telecommunications sectors)

  • FINRA Registered 

  • Principal investor in private equity and early to mid stage venture capital 

  • Public policy analyst and public sector transparency advocate



Patents: Two issued utility patents 9,399,117 and 10,293,141 

               - Patent pending in EU, Canada, and China

Manufacturing: Cathaid™ has contracted a major US converter to begin production with a clear path to reduce the COG. 

Pilot Test: Cathaid™ completed it's first patient usability trial with favorable results.

Commercialization: Cathaid™ aims to be fully commercialized by the middle of 2021. 

Staff: John W. Richards, Jr., MD, MMM, CPE, a pioneer of medical innovations and serial entrepreneur, joins the Cathaid™ team. He brings with him over 25 years of experience and knowledge. 

Clinical Trials: Further clinical trials have been scheduled.  



Tel: 706-840-2488

Cathaid Inc.

4487 Columbia Road Suite 201

Martinez, GA 30907

  • LinkedIn Social Icon
  • Facebook
  • Twitter

Invest in Cathaid™

We are currently in the seed round of fundraising. If you're interested in investing in Cathaid™, please contact us for more information. 

Name *

Email *


Success! Message received.